Related references
Note: Only part of the references are listed.T cell senescence and CAR-T cell exhaustion in hematological malignancies
Dimitri Kasakovski et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells
Mateusz Legut et al.
BLOOD (2018)
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy
Sara Sandri et al.
ONCOTARGET (2017)
c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals
Christopher D. Nishimura et al.
BLOOD (2017)
Higher PD-1 expression concurrent with exhausted CD8+T cells in patients with de novo acute myeloid leukemia
Jiaxiong Tan et al.
CHINESE JOURNAL OF CANCER RESEARCH (2017)
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS
Isao Tawara et al.
BLOOD (2017)
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease
Sara Mastaglio et al.
BLOOD (2017)
TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1
Lorenz Jahn et al.
BLOOD (2017)
Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies
Sara Sandri et al.
CANCER RESEARCH (2016)
A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer
Lorenz Jahn et al.
ONCOTARGET (2016)
Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies
Lorenz Jahn et al.
ONCOTARGET (2016)
Novel immunotherapy for adult T-cell leukemia/lymphoma: Targeting aurora kinase A
Nicholas Paul Casey et al.
OncoImmunology (2016)
Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street
David M. Barrett et al.
JOURNAL OF IMMUNOLOGY (2015)
Antileukemia multifunctionality of CD4+ T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer
H. Fujiwara et al.
LEUKEMIA (2015)
Hematopoietic stem cells for cancer immunotherapy
Eric Gschweng et al.
IMMUNOLOGICAL REVIEWS (2014)
Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors
Hiroshi Fujiwara
INTERNATIONAL JOURNAL OF HEMATOLOGY (2014)
Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia
Yukihiro Miyazaki et al.
BLOOD (2013)
MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer
Jia Li et al.
CANCER CELL INTERNATIONAL (2013)
HLA-DPB1*05:01-restricted WT1 332-specific TCR-transduced CD4+ T Lymphocytes Display a Helper Activity for WT1-specific CTL Induction and a Cytotoxicity Against Leukemia Cells
Yuhung Lin et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity
Kozo Nagai et al.
BLOOD (2012)
TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo
Stefani Spranger et al.
BLOOD (2012)
Cellular damage and apoptosis along with changes in NF-kappa B expression were induced with contrast agent enhanced ultrasound in gastric cancer cells and hepatoma cells
Zao Jiang et al.
CANCER CELL INTERNATIONAL (2012)
Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivity
Luise U. Weigand et al.
IMMUNOLOGY (2012)
Challenges in T cell receptor gene therapy
Benjamin J. Uttenthal et al.
JOURNAL OF GENE MEDICINE (2012)
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Elena Provasi et al.
NATURE MEDICINE (2012)
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
Toshiki Ochi et al.
BLOOD (2011)
WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval
Anri Saitoh et al.
MEDICAL ONCOLOGY (2011)
WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient
Yusuke Oji et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia
Toshiki Ochi et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell
Thomas Serwold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Adoptive Immunotherapy of Disseminated Leukemia With TCR-transduced, CD8+ T Cells Expressing a Known Endogenous TCR
Michelle L. Dossett et al.
MOLECULAR THERAPY (2009)
WT1-specific T cell receptor gene therapy: Improving TCR function in transduced T cells
Hans J. Stauss et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Redirecting T lymphocyte specificity by T cell receptor gene transfer - A new era for immunotherapy
Boris Engels et al.
MOLECULAR ASPECTS OF MEDICINE (2007)
αβ T-cell receptor engineered γδ T cells mediate effective antileukemic reactivity
LT van der Veken et al.
CANCER RESEARCH (2006)
Generation of tumor-specific T-cell therapies
E Morris et al.
BLOOD REVIEWS (2006)
Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derviative is governed by the CD8 coreceptor and affects natural human TCR expression
Ralf-Holger Voss et al.
IMMUNOLOGIC RESEARCH (2006)
Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells
SA Xue et al.
BLOOD (2005)
Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells:: artificial APCs pave the way for clinical application by potent primary in vitro induction
K Schilbach et al.
BLOOD (2005)
Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity
MP Rubinstein et al.
JOURNAL OF IMMUNOLOGY (2003)
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer
T Stanislawski et al.
NATURE IMMUNOLOGY (2001)
Share Paper
